{"id":199,"date":"2026-03-24T08:47:48","date_gmt":"2026-03-24T08:47:48","guid":{"rendered":"https:\/\/air-compressor-for-laser-cutter.com\/?p=199"},"modified":"2026-03-31T07:40:48","modified_gmt":"2026-03-31T07:40:48","slug":"oil-free-air-compressor-designed-for-pharmaceutical-production-and-sterile-filling-processes","status":"publish","type":"post","link":"https:\/\/air-compressor-for-laser-cutter.com\/fr\/application\/oil-free-air-compressor-designed-for-pharmaceutical-production-and-sterile-filling-processes\/","title":{"rendered":"Oil-Free Air Compressor Designed for Pharmaceutical Production and Sterile Filling Processes"},"content":{"rendered":"
\n

<\/p>\n

\n
<\/div>\n
<\/div>\n
\n

Pharmaceutical Manufacturing \u00b7 United Kingdom<\/span><\/p>\n

Oil-Free Air Compressor Designed for Pharmaceutical Production and Sterile Filling Processes<\/h2>\n

How ISO 8573-1 Class 0 oil-free compression technology is redefining contamination control, GMP compliance, and energy efficiency across UK sterile drug manufacturing, tablet production, and aseptic vial filling operations.<\/p>\n<\/div>\n<\/div>\n

<\/p>\n

\n

\"compresseurCompressed air sits at the intersection of almost every critical process in pharmaceutical manufacturing. Tablet press actuation, vial filling conveyors, reactor valve control, cleanroom HVAC dampers, lyophiliser loading mechanisms, and instrument air loops across API synthesis suites all draw from the same central supply. What makes this utility so consequential is not its ubiquity \u2014 it is the direct product contact risk that comes with it. A single, measurable trace of hydrocarbon contamination in a product-contact airstream can trigger a full batch rejection, an MHRA Corrective and Preventative Action, and in the most serious cases, a recall that dwarfs any capital saving achieved by running cheaper compressed air equipment. This is the industrial reality that drives the growing adoption of the pharmaceutical-grade oil-free air compressor across UK manufacturing sites of every scale.<\/p>\n

Ever Power has been designing, supplying, commissioning, and servicing oil-free compressed air systems for pharmaceutical manufacturers across England, Scotland, Wales, and Northern Ireland for more than a decade. Our application engineers carry both compressed air system design experience and a working understanding of the MHRA expectations, EU GMP Annex 1 (revised 2022), and the ISO 8573-1 Class 0 standard that now defines what a defensible pharmaceutical compressed air system must deliver. We know that a pharmaceutical project engineer asking for a compressor quotation is also asking for a documentation package, a commissioning programme, a service structure, and a supplier relationship that will survive an MHRA inspection without producing uncomfortable findings.<\/p>\n

Whether you are specifying a compact laboratory oil-free compressor for a QC department in the South East, replacing ageing rotary screw plant at a solid-dose site in West Yorkshire, or commissioning a large N+1 central compressed air plant room for a new sterile injectables facility in the East Midlands, the fundamental engineering and regulatory requirements remain consistent: zero oil contamination, validated performance, a clean and auditable documentation trail, and a supplier who picks up the phone when your critical utility alarms at 02:00 on a Sunday morning.<\/p>\n<\/div>\n

<\/p>\n

\n

\"compresseurEver Power EP-OF Series Oil-Free Pharmaceutical Air Compressor \u2014 ISO 8573-1 Class 0 Certified, GMP-Documented<\/p>\n

\ud83d\udce7 Request a Free Pharmaceutical Compressor Quote<\/a><\/p>\n<\/div>\n

<\/p>\n

\n

The Regulatory Case for Oil-Free Compressed Air in Pharmaceutical Manufacturing<\/h2>\n

\"compresseurThe pharmaceutical sector operates under a level of compressed air scrutiny that general industrial users rarely encounter. MHRA site inspections examine compressed air as a critical utility. EU GMP Annex 1 (2022 revision) explicitly references compressed air within the Contamination Control Strategy, requiring that its quality be risk-assessed and verified through a validated monitoring programme. When an MHRA inspector sits across the desk and asks to see your compressed air risk assessment, a response built around oil-injected compression with downstream coalescing filtration faces a straightforward challenge: filter bypass events, maintenance interval slip, activated carbon bed saturation, and the thermal cycling effects that degrade filter media over time are all failure modes that introduce real hydrocarbon contamination risk. An oil-free pharmaceutical air compressor eliminates those failure modes at source. There is no oil in the compression element, so there is no credible contamination pathway from the compressor to the product airstream, regardless of downstream filter condition.<\/p>\n

The 2022 revision of Annex 1 has sharpened the regulatory spotlight on utilities management more broadly. The requirement for a Contamination Control Strategy that covers all product contact utilities \u2014 including compressed air \u2014 means that sites still relying on oil-injected compressors with downstream filtration are increasingly finding themselves writing more complex justifications than their competitors running Class 0 oil-free plant. That documentation burden, combined with the quarterly compressed air sampling costs and the perpetual anxiety around filter condition, makes the economics of switching to oil-free more compelling than ever when viewed on a five-year horizon rather than a capital expenditure line item.<\/p>\n

Modern oil-free pharmaceutical air compressors have simultaneously become significantly more energy-efficient than the technology available a decade ago. Variable speed drive motors that modulate output to match real-time pharmaceutical process demand \u2014 the rapid air surges of filling machine pneumatics, the steady consumption of cleanroom HVAC actuators, the stepped demand of tablet press operations \u2014 deliver energy savings of 20\u201335% compared with fixed-speed alternatives running at constant load. Integrated heat recovery can return up to 94% of compression input energy as usable heat for space heating or process water, giving pharmaceutical facilities a tangible contribution toward their net-zero commitments. The oil-free pharmaceutical air compressor has moved from being a regulatory compliance item to a genuine strategic asset in the modern pharmaceutical facility.<\/p>\n<\/div>\n

<\/p>\n

\n

Six Reasons UK Pharmaceutical Manufacturers Specify Ever Power<\/h2>\n
\n
\n
\ud83c\udfe5<\/div>\n

ISO 8573-1 Class 0 \u2014 Third-Party Verified<\/h3>\n

Every EP-OF series pharmaceutical oil-free compressor ships with accredited third-party test certification confirming zero detectable oil aerosol, oil vapour, and liquid oil contamination across all rated operating conditions. Not a paper claim \u2014 a measured, documented result that stands up in front of an MHRA inspector.<\/p>\n<\/div>\n

\n
\u26a1<\/div>\n

Variable Speed Drive \u2014 Standard Across the Range<\/h3>\n

Permanent magnet VSD motors respond to the fluctuating compressed air demand patterns characteristic of pharmaceutical process plants \u2014 filling line cycles, pneumatic conveying surges, instrument air peaks \u2014 maintaining outlet pressure within \u00b10.1 bar while cutting energy consumption by 20\u201335% versus fixed-speed alternatives.<\/p>\n<\/div>\n

\n
\ud83d\udccb<\/div>\n

Full GMP Documentation Package<\/h3>\n

Design Qualification (DQ), Factory Acceptance Test (FAT), Installation Qualification (IQ) protocols and executed reports provided as standard. Material traceability certificates, CE Declaration of Conformity, PSSR 2000 compliance documentation, and noise assessment reports available for all UK installations.<\/p>\n<\/div>\n

\n
\ud83c\udf21\ufe0f<\/div>\n

Integrated Heat Recovery \u2014 Up to 94%<\/h3>\n

The compression process generates significant recoverable heat. Ever Power’s integrated heat recovery module captures up to 94% of input energy as hot water or warm air, contributing directly to pharmaceutical site sustainability targets and reducing the net operating cost of the compressed air system year-on-year.<\/p>\n<\/div>\n

\n
\ud83d\udce1<\/div>\n

SMARTLINK Remote Monitoring<\/h3>\n

Integrated controller logs pressure, temperature, pressure dew point, flow, and running hours continuously. OPC-UA and Modbus TCP data outputs integrate with Siemens, Rockwell, and DeltaV SCADA platforms. QA alarm escalation to mobile devices delivers real-time critical utility surveillance between formal requalification campaigns.<\/p>\n<\/div>\n

\n
\ud83d\udd27<\/div>\n

Extended Service Intervals \u2014 8,000 Hours<\/h3>\n

Oil-free compression element design allows 8,000-hour service intervals \u2014 nearly double the industry standard. Fewer planned maintenance shutdowns mean less contamination risk from service interventions, lower annual maintenance spend, and a compressed air system that is available when pharmaceutical production needs it most.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

EP-OF Series: Technical Performance at a Glance<\/h2>\n

All models in the EP-OF pharmaceutical oil-free compressor range comply with ISO 1217 Edition 4 for free air delivery measurement, ISO 8573-1:2010 for compressed air purity, and PSSR 2000 (England, Wales, Scotland) \/ PSSR (NI) 2000 for pressure system safety. Custom configurations \u2014 including N+1 duty\/standby pairs, skid-mounted integrated treatment trains, ATEX Zone 2 variants, and bespoke controller specifications \u2014 are available across all model sizes. Contact the Ever Power pharmaceutical team for application-specific sizing guidance.<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n
Mod\u00e8le<\/th>\nFAD (m\u00b3\/min)<\/th>\nMax Pressure (bar g)<\/th>\nMotor (kW)<\/th>\nOil Class<\/th>\nBruit dB(A)<\/th>\nCooling<\/th>\nDrive<\/th>\n<\/tr>\n<\/thead>\n
EP-OF-15<\/td>\n0.8 \u2013 1.6<\/td>\n10<\/td>\n15<\/td>\nClass 0<\/span><\/td>\n62<\/td>\nAir<\/td>\nVSD<\/td>\n<\/tr>\n
EP-OF-30<\/td>\n1.6 \u2013 3.5<\/td>\n10<\/td>\n30<\/td>\nClass 0<\/span><\/td>\n63<\/td>\nAir<\/td>\nVSD<\/td>\n<\/tr>\n
EP-OF-55<\/td>\n3.5 \u2013 6.8<\/td>\n10<\/td>\n55<\/td>\nClass 0<\/span><\/td>\n65<\/td>\nWater<\/td>\nVSD<\/td>\n<\/tr>\n
EP-OF-90<\/td>\n6.8 \u2013 11.2<\/td>\n10<\/td>\n90<\/td>\nClass 0<\/span><\/td>\n66<\/td>\nWater<\/td>\nVSD<\/td>\n<\/tr>\n
EP-OF-132<\/td>\n11.2 \u2013 17.5<\/td>\n10<\/td>\n132<\/td>\nClass 0<\/span><\/td>\n67<\/td>\nWater<\/td>\nVSD + Fixed<\/td>\n<\/tr>\n
EP-OF-200<\/td>\n17.5 \u2013 26.0<\/td>\n10 \/ 13<\/td>\n200<\/td>\nClass 0<\/span><\/td>\n68<\/td>\nWater<\/td>\nVSD + Fixed<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

Free Air Delivery (FAD) measured at inlet conditions per ISO 1217:2009 Edition 4. All models available as standard in 50 Hz \/ 400 V three-phase configuration. CE marked. Compliant with UK PSSR 2000 and PSSR (NI) 2000. Data valid at sea level, 20\u00b0C inlet temperature. Contact Ever Power for high-altitude or elevated-temperature de-rating calculations.<\/p>\n<\/div>\n

<\/p>\n

\n

Compression Technology, Materials, and Pharmaceutical Design Standards<\/h2>\n
\n
\n

Two-Stage Dry Screw Compression<\/h3>\n

Synchronised contra-rotating male and female rotors trap and compress atmospheric air in two stages entirely without oil contact. PTFE-coated rotor profiles and food-grade PTFE shaft seals prevent any hydrocarbon transfer from the mechanical assembly to the compressed airstream. Because there is no oil in the compression element, there is no oil separator vessel to bypass, no activated carbon adsorber to saturate, and no pathway through which the contamination events that affect filtered oil-injected systems can reach the pharmaceutical process. Delivery air temperatures in the two-stage dry design remain below 55\u00b0C at the compression outlet, with further intercooling dropping delivery air to within 10\u201315\u00b0C above ambient before the downstream dryer.<\/p>\n<\/div>\n

\n

Water-Injected Single-Stage Screw (55\u2013200 kW)<\/h3>\n

For the mid and large pharmaceutical oil-free compressor models, water injection into the compression chamber achieves near-isothermal compression \u2014 purified water droplets absorb compression heat, lubricate the rotor surfaces, and seal the working clearances. Water is separated in a closed-loop system, passed through a heat exchanger, and re-injected continuously. Compression outlet air temperatures of 40\u201345\u00b0C are typical \u2014 particularly valuable for temperature-sensitive instrument air systems serving pharmaceutical analyser networks. The water used is demineralised to a conductivity below 10 \u03bcS\/cm and is continuously monitored for bacterial count where site water quality validation demands it.<\/p>\n<\/div>\n

\n

Pharmaceutical-Grade Material Selection<\/h3>\n

All components in contact with the compressed airstream are manufactured from 316L stainless steel, PTFE, or FDA 21 CFR-compliant elastomers. Air receivers are available with electropolished internal surfaces (Ra below 0.8 \u03bcm) and passivation treatment for sites requiring full cleanability of the pressure system. External enclosures are finished with antimicrobial powder coating \u2014 a practical consideration for equipment installed in or adjacent to pharmaceutical cleanroom service corridors. All gaskets and seals carry full material compliance declarations. Stainless steel compression outlet manifolds, sampling ports with tri-clamp connections, and pharmaceutical-grade compressed air quality monitoring points are standard options across the EP-OF range.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Where a Pharmaceutical Air Compressor Delivers Critical Value<\/h2>\n

Compressed air touches more unit operations in pharmaceutical manufacturing than most project engineers initially recognise at the start of a facility design. The following application areas represent the primary contexts in which an Ever Power oil-free pharmaceutical air compressor delivers measurable process performance, contamination control, and compliance benefit across UK sites.<\/p>\n

\n
\n

\ud83d\udc8a Tablet & Capsule Manufacturing<\/h3>\n

Tablet press pneumatic systems, film coating pan air supply (where compressed air forms part of the spray atomisation), capsule filling machine actuators, blister thermoforming seal air, and carded product cartoning pneumatics all require a clean, dry compressed air supply. Even marginal hydrocarbon contamination in coating spray air can affect film thickness uniformity \u2014 a directly measurable critical quality attribute for modified-release products. The pharmaceutical oil-free air compressor eliminates this risk entirely and removes the periodic testing cost associated with demonstrating that downstream filtration remains effective.<\/p>\n<\/div>\n

\n

\ud83d\udc89 Aseptic Liquid Filling & Lyophilisation<\/h3>\n

Vial filling and rubber stoppering machines, pre-filled syringe assembly lines, ampoule sealing stations, lyophiliser loading robot pneumatics, and stopper insertion actuators in Grade A environments all depend on Class 0 compressed air. A contamination event in a Grade A filling suite triggers a mandatory environmental monitoring deviation, a batch disposition decision, and potentially a formal deviation investigation that halts production. The cost of that single event \u2014 in batch loss, investigation time, and regulatory reporting \u2014 is routinely many times the entire capital cost of the oil-free pharmaceutical compressor that would have prevented it.<\/p>\n<\/div>\n

\n

\ud83e\uddea API Synthesis & Reaction Vessels<\/h3>\n

Reactor agitator drive systems, pressure\/vacuum switching manifolds, pneumatic control valve actuators throughout API synthesis operations, and inert gas blanketing assistance systems all draw from compressed air or compressed gas utilities that must be verified contaminant-free. Oil contamination in instrument air serving reactor control valves causes valve stiction, erratic pressure regulation, and ultimately batch failure in multi-day synthesis campaigns where a single production loss runs to tens of thousands of pounds in API value and recovery cost.<\/p>\n<\/div>\n

\n

\ud83c\udfed Cleanroom HVAC Pneumatics<\/h3>\n

Air handling unit damper actuators, variable air volume controllers, pressure differential monitoring systems, and biosafety cabinet pneumatic interlock mechanisms in pharmaceutical cleanrooms must be supplied from a confirmed Class 0 source. Many UK pharmaceutical manufacturers now specify oil-free compressed air as the default supply for all HVAC pneumatic controls across their site, not only for product-contact applications, because the incremental cost of extending the oil-free ring main is negligible compared with the cost of maintaining a separate filtered supply system for HVAC-only duties.<\/p>\n<\/div>\n

\n

\ud83d\udce6 Secondary Packaging & Serialisation<\/h3>\n

Cartoning machine pneumatics, tamper-evident banding application, pack leaflet insertion actuators, and vision system purge air on track-and-trace serialisation lines are all served from the site compressed air ring main. While secondary packaging carries lower direct contamination risk than filling operations, UK pharmaceutical manufacturers increasingly include secondary packaging compressed air in routine monitoring programmes. Having a single Class 0 supply ring main that covers both product-contact and non-product-contact applications simplifies the monitoring scheme and reduces the quality system overhead associated with maintaining separate classified and unclassified air systems.<\/p>\n<\/div>\n

\n

\ud83d\udd2c Laboratory & QC Instrumentation<\/h3>\n

HPLC mobile phase degassing, dissolution apparatus gas supply, particle counter calibration air, GC\/MS instrument purge lines, and Karl Fischer moisture analyser carrier gas streams all demand hydrocarbon-free compressed air at relatively low flow rates. Ever Power’s compact bench-top and under-bench EP-OF-15 pharmaceutical air compressor models serve QC laboratories where floor space is at a premium and air purity specifications are as uncompromising as on the main production floor \u2014 in some respects, more so, because analytical instrument contamination can invalidate release testing data across multiple batches.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Customer Success Story: Sterile Injectables CDMO, East Midlands, UK<\/h2>\n

Site identity protected under standard confidentiality arrangements. Full case study available under NDA on request.<\/p>\n

\n
\n

The Challenge<\/p>\n

A mid-size UK contract development and manufacturing organisation was commissioning a new Grade B sterile injectables facility near Nottingham. The compressed air specification required ISO 8573-1 Class 0 purity, N+1 duty\/standby redundancy, full GMP qualification documentation, and OPC-UA integration with the site’s critical utilities SCADA. A previous project with a major European OEM had left the engineering team frustrated by slow documentation delivery, an absence of UK-based commissioning resource, and a controller platform with no native SCADA connectivity. Regulatory submission timelines meant there was no room for documentation delays a second time.<\/p>\n<\/div>\n

\n

The Solution<\/p>\n

Ever Power supplied a skid-mounted duty\/standby pair of EP-OF-55 pharmaceutical oil-free air compressors with integrated refrigerant dryers, sterile-grade 0.01 \u03bcm coalescing post-filters, and a shared air receiver. The complete GMP documentation pack \u2014 DQ report, FAT protocol and report, IQ protocol \u2014 was delivered against a pre-agreed schedule that had been written into the purchase order. The SMARTLINK controllers were pre-configured for OPC-UA output to the site SCADA, with alarm escalation to the site QA manager’s mobile device programmed before despatch. An Ever Power UK commissioning engineer was on site for three days during SAT execution and delivered first-line operator training to the client’s engineering team.<\/p>\n<\/div>\n

\n

The Outcome<\/p>\n

The compressed air system cleared the MHRA pre-approval inspection with no critical or major observations against the utility supply. Eighteen months of continuous dew point monitoring showed zero excursions from the site’s internal limit of \u221240\u00b0C PDP. Measured energy consumption confirmed a 27% saving versus the fixed-speed system in the original engineering budget. The CDMO subsequently placed a repeat order for a second oil-free pharmaceutical compressor installation at a new facility in the North West of England \u2014 the clearest endorsement we can offer of how the project landed.<\/p>\n<\/div>\n<\/div>\n

<\/p>\n

What UK Pharmaceutical Engineers Say About Ever Power<\/h3>\n
\n
\n

“Two MHRA inspection cycles, zero observations against our compressed air utility. The documentation quality Ever Power delivered during commissioning saved us significant time during the regulatory submission. We would not hesitate to specify them again on the next project.”<\/p>\n

\u2014 Head of Engineering, Sterile Injectables CDMO, Nottinghamshire<\/p>\n<\/div>\n

\n

“We had been running oil-injected compressors with coalescing filtration for years and kept getting marginal results on quarterly compressed air hydrocarbon testing. Switching to the Ever Power oil-free pharmaceutical compressor solved the problem completely. Our QC team now reports total oil readings consistently below 0.01 mg\/m\u00b3.”<\/p>\n

\u2014 Utilities Manager, Solid-Dose Manufacturer, West Yorkshire<\/p>\n<\/div>\n

\n

“The custom skid Ever Power engineered for our API synthesis suite saved three weeks of installation time \u2014 the compressor, dryer, receiver, and monitoring instrumentation arrived pre-assembled and factory-tested. We hit our IQ milestone ahead of schedule and the remote monitoring capability has transformed how we manage compressed air as a critical utility.”<\/p>\n

\u2014 Project Engineering Lead, Active Pharmaceutical Ingredient Site, Cheshire<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Bespoke Engineering: Custom Pharmaceutical Compressor Packages from Ever Power<\/h2>\n
\n
\n

Pharmaceutical facility engineering is rarely standard, and standard catalogue equipment often does not precisely fit the demands of a complex, multi-product, multi-building pharmaceutical site. Ever Power’s in-house engineering team operates a dedicated pharmaceutical project manufacturing cell with the capability to design and build oil-free compressed air packages that are matched precisely to your process requirements, your quality system, and your site infrastructure. Our custom design capability covers output ranges from 50 L\/min for a standalone QC laboratory unit through to 26 m\u00b3\/min for a large central plant room in a full N+1+1 configuration with hot-swap redundancy and automatic load-balanced multi-compressor control.<\/p>\n

Custom pharmaceutical oil-free compressor projects we regularly deliver include: fully integrated skid packages combining the oil-free compressor, refrigerant or desiccant dryer, pre-filters, sterile-grade post-filters, instrumented stainless steel receiver, and interconnecting pipework in a single GMP-cleanable frame; ATEX Zone 2 and Zone 1 classified configurations for solvent-handling pharmaceutical areas; hot-standby redundant systems with automatic changeover within 0.5 seconds of a duty unit fault alarm; and bespoke SCADA integration packages covering Siemens S7, Rockwell ControlLogix, and Emerson DeltaV platforms. Every custom project begins with a no-cost application engineering review \u2014 send us your P&ID, instrument air schedule, and compressed air purity specification, and our team will return a detailed technical proposal within five working days.<\/p>\n<\/div>\n

\n

Custom Package Options<\/h3>\n